NCT04570150View on ClinicalTrials.gov

Optimizing Post-operative Recovery in Bariatric Patients With Obstructive Sleep Apnea Undergoing Outpatient Surgery: A Comparison of Sugammadex and Neostigmine

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2024

Conditions
Anesthesia
Interventions
DRUG

Sugammadex

Subjects who are randomized to into the sugammadex arm (Arm I) will receive sugammadex for reversal of neuromuscular block at the completion of their anesthetic; Outcomes measures will be recorded and compared with those from Arm II (neostigmine group).

DRUG

Neostigmine

Subjects who are randomized into the neostigmine arm (Arm II) will receive neostigmine for reversal of neuromuscular block at the completion of their anesthetic; Outcomes measures will be recorded and compared with those from Arm I (sugammadex group).

Trial Locations (1)

92037

University of California San Diego, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT04570150 - Optimizing Post-operative Recovery in Bariatric Patients With Obstructive Sleep Apnea Undergoing Outpatient Surgery: A Comparison of Sugammadex and Neostigmine | Biotech Hunter | Biotech Hunter